Dr. Nader serves as chairman of BenevolentAI (BAI) and as board director of Moderna (MRNA) and RING Therapeutics and as senior advisor of Blackstone Life Sciences. He is also the chairman of Jesra Foundation and of BioLink.org and a member of the Board of Trustees of the Lebanese American University, the American Task Force for Lebanon (ATFL) and advisor to LIFE. Dr. Nader is the recipient of the Lebanese National Order of Merit, the EY National Life Science Entrepreneur of the Year® award and the Ellis Island Medal of Honor. Previously, Dr. Nader was Chief Executive Officer of NPS Pharma. During his tenure, he transformed NPS Pharma into a leading global biotechnology company focused on delivering innovative therapies to patients with rare diseases. Before NPS, Dr. Nader was a venture partner at Care Capital. Prior, he served in several senior leadership positions at Aventis, Hoechst Marion Roussel and Pasteur Vaccins. Dr. Nader earned his French Doctorate in Medicine from St. Joseph University (Lebanon) and his Physician Executive MBA from the University of Tennessee.